Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Futoshi Kawamata

EGFR and Prion Protein Promote Signaling via FOXO3a-KLF5 Resulting in Clinical Resistance to Platinum Agents in Colorectal Cancer

Molecular Oncology

English

The Anti-Mesothelin Monoclonal Antibody Amatuximab Enhances the Anti-Tumor Effect of Gemcitabine Against Mesothelin-High Expressing Pancreatic Cancer Cells in a Peritoneal Metastasis Mouse Model

Oncotarget

Oncology

2018

English

Related publications

ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models

Molecular Cancer Therapeutics

Cancer Research

Oncology

2014

English

Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer

Nature

Multidisciplinary

2012

English

Molecular Determinants of Anti-Egfr Sensitivity and Resistance in Metastatic Colorectal Cancer

British Journal of Cancer

Cancer Research

Oncology

2010

English

mTOR Signaling Mediates Resistance to Tankyrase Inhibitors in WNT-Driven Colorectal Cancer

Oncotarget

Oncology

2017

English

Protein-Intrinsic and Signaling Network-Based Sources of Resistance to EGFR- And ErbB Family-Targeted Therapies in Head and Neck Cancer

Drug Resistance Updates

English

Colorectal Cancer Cell-Derived CCL20 Recruits Regulatory T Cells to Promote Chemoresistance via FOXO1/CEBPB/NF-κB Signaling

Journal for ImmunoTherapy of Cancer

English

Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling

Physiological Reviews

English

RhoA Regulates Resistance to Irinotecan by Regulating Membrane Transporter and Apoptosis Signaling in Colorectal Cancer

Oncotarget

Oncology

2016

English

Cancer‐associated Fibroblasts Secrete Wnt2 to Promote Cancer Progression in Colorectal Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Futoshi Kawamata

EGFR and Prion Protein Promote Signaling via FOXO3a-KLF5 Resulting in Clinical Resistance to Platinum Agents in Colorectal Cancer

The Anti-Mesothelin Monoclonal Antibody Amatuximab Enhances the Anti-Tumor Effect of Gemcitabine Against Mesothelin-High Expressing Pancreatic Cancer Cells in a Peritoneal Metastasis Mouse Model

Related publications

ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models

Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer

Molecular Determinants of Anti-Egfr Sensitivity and Resistance in Metastatic Colorectal Cancer

mTOR Signaling Mediates Resistance to Tankyrase Inhibitors in WNT-Driven Colorectal Cancer

Protein-Intrinsic and Signaling Network-Based Sources of Resistance to EGFR- And ErbB Family-Targeted Therapies in Head and Neck Cancer

Colorectal Cancer Cell-Derived CCL20 Recruits Regulatory T Cells to Promote Chemoresistance via FOXO1/CEBPB/NF-κB Signaling

Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling

RhoA Regulates Resistance to Irinotecan by Regulating Membrane Transporter and Apoptosis Signaling in Colorectal Cancer

Cancer‐associated Fibroblasts Secrete Wnt2 to Promote Cancer Progression in Colorectal Cancer